• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Eden Bioscience

Eden Bioscience

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Edenred Sees Venezuela, Brazil Currency Depreciation Hurting EBIT

    Edenred Sees Venezuela, Brazil Currency Depreciation Hurting EBIT

  2. UPDATE: Boomer travel: Planning a trip to Antarctica

    UPDATE: Boomer travel: Planning a trip to Antarctica

  3. UPDATE: 11 ways the Americans can beat Belgium

    UPDATE: 11 ways the Americans can beat Belgium

  4. NYPD's Facebook Page Shares Its Triumphs

    NYPD's Facebook Page Shares Its Triumphs

  5. Investing in Drought Solutions

    The views expressed in this document are expressions of opinion only and should not be construed as investment advice. Past performance may not be a reliable guide to future performance and the value of investments may fall as well as rise. This material is provided for informational purposes only ...

  6. Analyst Pick Artisan International Value Closes

    Plus, Fidelity launches distinctive muni funds, PIMCO cuts fees, and more.

  7. The Middle Ground

    The stocks mentioned in this article be holdings in the managed portfolios of Validea Capital Management, a separate asset management firm founded by Validea.com founder John Reese. Validea Capital Management, which an SEC registered investment advisory firm and a separate company from Validea.com, uses, in part, the strategies discussed in this article to select stocks for its clients.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.